![](/img/cover-not-exists.png)
A randomised phase II trial of the Polo-like kinase inhibitor BI 2536 in chemo-naïve patients with unresectable exocrine adenocarcinoma of the pancreas – a study within the Central European Society Anticancer Drug Research (CESAR) collaborative network
Mross, K, Dittrich, C, Aulitzky, W E, Strumberg, D, Schutte, J, Schmid, R M, Hollerbach, S, Merger, M, Munzert, G, Fleischer, F, Scheulen, M EVolume:
107
Language:
english
Journal:
British Journal of Cancer
DOI:
10.1038/bjc.2012.257
Date:
July, 2012
File:
PDF, 422 KB
english, 2012